chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt presented to urgent care 9/24/21 where she was referred to the ED. In the ED c/o of generalized body muscle weakness and joint pains since this morning. Pt states she woke up and was unable to move. Pt states, she had Flu vaccine and covid vaccine 9/21/22. Also reports body rash. Patient received supportive care, morphine and ketorolac. Pt was discharged home and instructed not to receive further influenze and/or COVID vaccines based on her reaction.
My child  has been diagnosed with autism for  which a decline in his growth was noticed post vaccination.
Patient states "The whole front side of my arm from site of inj. down to my elbow became red. I had stinging sensation and itching in this area. Used CORTIZONE cream on arm and took BENADRYL 50mgs Q4 hours till red area went away. This lasted from 11-11-15 to 11-22-15." No hardness/firmness noted at site of extended localized reaction.
After vaccine administration, within minute, brief period of unresponsiveness with seizure like activity, lasted about 10 seconds. Monitored patient 30 min.
Hospitalization for Trans-ischemic attack (TIA), sinusitis, COVID-19 infection, accelerated hypertension, hyperglycemia, hypomagnesemia, hyponatremia, gait instability, on dates 11/2/2023- 11/4/2023. Treated with vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Patient passed out briefly while walking down an aisle roughly three minutes after vaccine was administered. He was unresponsive for less than one minute.  Administering pharmacist, manager on duty, and parent were with patient. Patient moved himself into a chair and waited for paramedics to arrive. Paramedics checked patient out and recommended he go to a hospital  for further observation.  To our knowledge, the parent drove patient to hospital.
Information has been received from a claims administrator, concerning a male patient who on an unspecified date was vaccinated with a dose of ZOSTAVAX (Merck) (Lot # J001005, expiration date 24APR2014) along with diluent with (lot # H10635 and expiration date DECEMBER 2014). The patient had an adverse reaction (not further specified) to the ZOSTAVAX (Merck). It was unknown if the patient sought medical attention. Treatment and outcome of the adverse reaction was unknown. Additional information was requested.
pt recv vax 2MAY97 & that evening devel an inj site rxn characterized by a 3-4inc area of redness & swelling;2 days post vax pt ATB therapy was changed to Augmentin;inj site looked better next day;pt recovered;
This spontaneous report was received from a nurse refers to multiple patients of unknown age and gender. No pertinent medical history was reported. On an unknown date, multiple patients were vaccinated with ROTATEQ (lot # K004795 and expiration date 11-FEB-2016) post supported temperature excursion. No adverse effects were reported. This is one of the several reports from the same source. Additional information has been requested.
Moderna vaccine was administered outside of our facility - reported by patient ? NO LOT NUMBER WERE SUPPLIED ----------------------------------------------------------------------------------------------------------------------------------- I26.99 ACUTE PULMONARY EMBOLISM 2/28/2022 GERD (GASTROESOPHAGEAL REFLUX DISEASE) J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 2/28/2022 GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Stumbling and unsteadiness beginning 6 days after immunization. Improved over 1 week. Pertussis was withheld during this course of vaccination
warm, pain, redness 3x5 cm (L) upper arm, mild swelling. Pain in (L) arm hand. radiating arm no arthralgia no fever Injection 8/14 Pain developed 8/15-seen in office 8/17/07
Hard knot noted - approx 10-12 cm in diameter ten-fifteen minutes after injection given.
7APR91 rash trunk & diaper area faded in 3-4 days;
This spontaneous report as received from a healthcare worker refers to unknown number of patients of unknown age. The unknown number of patients had received ZOSTAVAX (lot number not provided) and VARIVAX (Merck) (lot number not provided) doses which were exposed to -6.8C for 1.5 hours every 24 hours due to defrost cycle every day. No adverse effect reported. It was unspecified if the patients had sought medical attention. The health care professional contacted during telephone follow-up did not remember which patient might have received these vaccines and could not supply the following information: patient name, date of birth, dates of vaccination, or lot number. She also stated that the vaccines have been moved to a proper storage unit. Follow-up information received from the healthcare worker. Patient information was updated. On 27-SEP-2013 the patient was vaccinated with a dose of improperly stored ZOSTAVAX (lot#, expiration date and route not reported). This is one of the several reports from the same source. Additional information has been requested.
06/21/2022- Severe Headache on top of head left side began and continued 24 hours a day. Took ibuprofen for pain. 06/24/2022- Began to breakout on left forehead. Thought it was an allergic reaction to eyebrow waxing I had earlier in the day. The breakout continued to increase over the next few days, even with the Benadryl and creams I was applying to it. 06/28/2022- Went to Urgent Care and was diagnosed with Shingles. Was prescribed an antiviral medication. Changed ibuprofen to acetaminophen due to bruising. SYMPTOMS: Severe headache (I usually experience no headaches), top of head was tender to touch (hurt to wash hair, brush/comb hair), forehead felt like a chemical burn (hurt for a hair shaft to touch it), left side of head and face was swollen, left eye was swollen almost shut. 7/8/2022- Symptoms were much improved. By the end of July, felt completely recovered.
1/27/2022- Presented to ER with complaints of a cough and feeling ill x 1 week. Afebrile. Vitals WNL. Covid + test. Chest x ray-unremarkable. Elevated troponin-0.462 r/t demand ischemia. Start  Eliquis. Hold monoclonals unless condition deteriorates.  1/28/2022- Asymptomatic. Troponin 0.387. vitals WNL. Discharged to home.
This is a spontaneous report from a contactable other hcp reported for herself. A 49-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number:EL9265), intramuscular on the right arm at the age of 49 years old, on 02Feb2021 at a SINGLE DOSE for covid-19 immunisation. Medical history reported as none. The patient had the first dose of the vaccine on 13Jan2021. The patient experienced fever 102, body aches, could barley move on 03Feb2021 12:00. The patient underwent lab tests and procedures which included body temperature: 102 on an unspecified date. The outcome of the event was not recovered.
Patient is a 75-year-old male  was admitted to the hospital with weakness.  He had high fever and fell at home unable to get up. Pt was diagnosed with COVID-19.  No respiratory symptoms.  Has been on room air with no cough or shortness of breath.  We kept the patient on observation for 24 hours as he is taking Coumadin.  CT of the head came back normal.  Negative blood cultures.  Patient was discharged and instructed to return if he had and SOB or cough.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 03Oct2021 at 12:00 as dose 3 (booster) single (Batch/Lot number: unknown) at the age of 54 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "hypothyroid" (unspecified if ongoing); "allergies" (unspecified if ongoing); "Known allergies: Sulfa" (unspecified if ongoing); "Known allergies: Gluten" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Cephalosporins, reaction(s): "Known allergies: Cephalosporins". The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course:Anti-viral details: product: COVID 19 Treatment,Brand: Pfizer,Treatment start date: 20May2022,Lot number: GA5120,Indication: Treatment of COVID-19,Vaccine lot unknown reason: Unable to locate or read the details,Adverse event: Aches, headache - more than day 1 of COVID,Adverse event country: Adverse event start date: 22May2022,Adverse event start time: 10:00 PM,patient recovered was not Recovered treatment AE: No,Known allergies: Sulfa, Cephalosporins, Gluten.Other medical history: Asthma, hypothyroid, allergies.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
passed out; skull fracture; syncopal episode; This spontaneous report was received from a nurse prescriber and refers to a 16-year-old male patient. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.     On an unknown date  (reported as recent), the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9), intramuscular for prophylaxis (dose, site of administration, lot# and expiration date were not reported).  Upon check-out at the office, the patient passed out, had a syncopal episode and experienced a skull fracture.   The outcome of the events and relatedness between the events and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) were not reported.  Upon internal review, the all of the events were considered to be medically significant.
No additional AE reported; patient was given an expired ROT ATEQ vaccine; a temperature excursion; This spontaneous report was received from a nurse and refers to a 3-month-old patient of an unknown gender. No information regarding the patient's medical history, concurrent conditions or concomitant medications was provided. On 13-APR-2021, the patient received incorrectly stored and expired dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot # 1660957with expiration date on 07-APR-2021, orally (exact dose was not reported) for prophylaxis. The vaccine underwent the temperature excursion of 61.1 degrees Fahrenheit for 4 hours and 30 minutes on 09-APR-2021. No previous excursion occurred. The digital data logger was not involved. No adverse events were reported.
Headache, Myalgia, Arm pain at injection site and worsening of symptoms Narrative:  Progressive headache symptoms and arm pain
Information has been received from a medical assistant concerning a 9 year old male patient with no pertinent medical history and no drug reactions/allergies who on 20-AUG-2010 was vaccinated subcutaneously with first dose of VARIVAX (Merck) (lot # 668078/0718Z, expired on 14-MAY-2012). There was no concomitant medication. On 21-AUG-2010, the patient developed local injection site reaction. The redness has increased to "soft ball" size but without any swelling. The patient had sought unspecified medical attention. No laboratory diagnostic study was performed. At the time of the report, the patient was recovering. Follow-up information has been received from the medical assistant concerning this male patient who on 20-AUG-2010 was vaccinated subcutaneously in left arm with the second dose (previously reported as the first dose) of VARIVAX (Merck) (lot # 668078/0718Z). There was no illness at time of vaccination. It was reported that the patient developed soft ball size redness swollen on 23-AUG-2010. The patient did not require emergency room/doctor visit. Ice, ibuprofen and BENADRYL were given. At the time of the report, the patient had recovered. Additional information is not expected.
I was having normal injection site soreness, so would gently massage to help ease the length of time i might feel this. I was rising from a chair to go get a glass of water and as i stood up began to massage my injection site. I believe i put too much pressure on the site, as i immediately felt warm and tingly all over and feared i may faint. I made my way to the fridge for water, but felt i was about to faint. I held on to the fridge handle to safely make my way to the floor, and woke up some time later on the kitchen floor.   I had not had much to eat that day, and i had also drank one beer with my cousin that evening. I don't feel as though this was vaccine related in any way other than my pain response from massaging the injection site caused me to faint, but I'm also not a scientist or related medical professional so i figured it best to let you know and make that judgement.
Information has been received from a physician concerning a 68 year old female consumer with no known allergies who on 07-AUG-2007 was vaccinated SQ with a dose of zoster vaccine live (Oka/Merck). On 24-MAR-2008, the patient developed shingles. The patient had rashes on her back, side of her head, and on her neck. She also complained of pain on the head and neck. On an unspecified date the patient was seen by the physician. It was unspecified if lab studies were performed. At the time of the report the patient's status was unknown. There was no product quality complaint involved. Follow-up information from the physician's office concerning a 68 year old consumer with no known allergies who on 07-AUG-2007 was vaccinated with zoster vaccine live (Oka/Merck) indicated there was no illness at the time of vaccination, and the patient did not have any lab studies performed. The patient's outcome was not reported. Follow-up information has been received from a physician concerning this 68 year old female consumer with no known allergies or pertinent medical history who on 07-AUG-2007 was vaccinated IM right side (also reported as SQ) with a first dose of zoster vaccine live (Oka/Merck) (lot # "07334'). There was no illness at the time of vaccination. On 29-MAR-2008 the patient was diagnosed with shingles. There were no lab studies performed. At the time of the report the patient's status was reported as recovered. (The patient does not have pain, but still has marks). It was noted that the patient did not have a rash at the site of injection or elsewhere within 42 days of the vaccination. The patient did developed lesions at the C3 location. The patient also developed pain (rated 4 on a scale of 0 to 10). It was also note that there was no recent exposure to chickenpox or herpes zoster. It was unspecified if the patient had a history of chickenpox. Additional information is not expected.
Hives on legs, hips, torso and underarms; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 29Mar2021 at 11:45 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was not reported. Concomitant medications included ethinylestradiol, levonorgestrel (SRONYX) since an unknown start date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 29Mar2021 the patient experienced hives at night only on legs, hips, torso and underarms up to 2 weeks after initial vaccination. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event hives on legs, hips, torso and underarms was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
this morning I noticed swelling and pain in the lymph nodes under my left arm, no redness or warmth just swelling and pain/tenderness
Mild rash, bumps on legs, head, arm, jawline. Look like hives. Patient referred to private MD.
c/o redness, swelling, warmth & itching to injection site, as well as continual headache.
This spontaneous report as received from a healthcare worker refers to unspecified patients of unknown age and gender. There were no concomitant medications, concurrent conditions and medical history reported. On an unknown dates since 06-NOV-2015, the patients were vaccinated with ROTATEQ orally, lot # L013193, expiration date 20-JAN-2017 and lot # K022990, expiration date 26-JUN-2016 (dose and site of administration were not reported), which were exposed to temperatures outside of the recommended range. There was no adverse effects reported. No product quality issue was involved. This is one of several reports received from the same reporter. Additional information has been requested.
fever 102, moaning, lethargic, high pitched cry began 1-2 hrs p/vax, lasted 12 hrs;
Hypertensive crisis; Flushing in face, it became red, and swollen; Flushing in face, it became red, and swollen; Flushing in face, it became red, and swollen; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced a hypertensive crisis, flushing in face, it became red and swollen.   The patient's medical history was not provided. No concomitant product use was reported.  On an unknown date, the patient received their first of two planned doses of mRNA-1273 (Lot number: 041L20A) intramuscularly for prophylaxis of COVID-19 infection.   On the unknown date, approximately half an hour after receiving the Moderna COVID-19 vaccine, the patient had facial flushing, it was red and swollen. The patient was taken to the emergency room for hypertensive crisis. Her blood pressure was 250/150 mmHg. She was in the emergency room for four hours until her blood pressure came down. Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not provided.   The outcome of the events, hypertensive crisis, flushing in face, it became red and swollen, was unknown.; Reporter's Comments: This spontaneous report (which concerns a female patient who experienced hypertensive crisis and flushing in face and it became red and swollen. The events occurred half hour after the administration of mRNA-1273 vaccine (Lot number: 041L20A, expiration date: unknown).   Based on the information provided which shows a temporal association, a causal association between the reported events and the administration of mRNA-1273 vaccine cannot be excluded.
Hot flashes; Fever; Headache; Jaw pain; Arm soreness; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 20Apr2021 at 10:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included cannabis sativa (MARIJUANA); from unknown date for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 30Mar2021 at 14:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021, the patient experienced hot flashes, fever, headache, jaw pain and arm soreness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events hot flashes, fever, headache, jaw pain and arm soreness was not recovered at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
I received the vaccine at 3;30 in the afternoon of 2/12/21. I felt fine and after waiting for 20 minutes, I drove home. I had no pain at the injection site and did not need any medication.  I ate dinner and went to bed at 10:30 pm.  I awoke at 1:30 am with pain in my mouth.  I had had a temporary bridge put in my upper right side of my mouth on Tuesday, 2/9/21.  I had had no pain from that dental procedure till 2/13/21 at 1:30 am.  I needed to take an Advil to relieve the pain.  After 20 minutes the pain was gone.  This pattern of waking at night with pain has continued since that night.  I called my dentist today and reported what was going on.  He told me to get in touch with the CDC and file a report.  He reported that he has heard of this pain occurring in other dental patients after having received the vaccine.
Shortness of breath; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath) and NAUSEA (nausea) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Shortness of breath) and NAUSEA (nausea). At the time of the report, DYSPNOEA (Shortness of breath) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided. No treatment information provided.
Starting Nov 8, experience severe sore throat, low grade fever, terrible cough, and stuffy nose. Very tired and in bed 5 days. Saw physician on Nov 9.
Pt received Moderna Vaccines on 04/05/21 and 05/03/21. Pt presented to the ED on 11/24/21 with complaints of SOB and fatigue. Pt was found to be COVID positive. Pt required supplemental oxygen.
This report was received from Pfizer and was assigned manufacturer report number 2016451998 for PREVNAR 23. Information has been received from a currently 77 year old female patient referring to herself. The patient's concurrent condition, medical history and concomitant medication were not reported. In 1994 or 1999 (not sure which year), the patient received her first pneumonia shot (manufacturer unknown) (lot #, expiration date, dose and route were not reported). It was reported there was no reaction except maybe a little bit of a sore arm. After receiving the shot in 1994 or 1999 (prior to 2005, date unspecified), the patient had pneumonia. She was unsure if she had arm tenderness at that time. The outcome of pneumonia and sore arm was unknown. The causality between the events and the pneumonia shot (manufacturer unknown) was not reported. Upon internal review, pneumonia was considered to be medically significant. Additional information has been requested.